Published in J Clin Invest on December 01, 1971
Comparison in different species of biliary bilirubin-IX alpha conjugates with the activities of hepatic and renal bilirubin-IX alpha-uridine diphosphate glycosyltransferases. Biochem J (1977) 1.26
Bilirubin diglucuronide synthesis by a UDP-glucuronic acid-dependent enzyme system in rat liver microsomes. Proc Natl Acad Sci U S A (1979) 1.14
Comparison of the biliary excretion of the four isomers of bilirubin-IX in Wistar and homozygous Gunn rats. Biochem J (1977) 0.91
Stimulation of bilirubin catabolism in jaundiced Gunn rats by an induced of microsomal mixed-function monooxygenases. Proc Natl Acad Sci U S A (1978) 0.85
Danger of bucolome in infants with hyperbilirubinaemia. Experimental evidence. Arch Dis Child (1978) 0.75
The use of jejunal transplants to treat a genetic enzyme deficiency. Ann Surg (1996) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Pharmacological implications of microsomal enzyme induction. Pharmacol Rev (1967) 13.35
The excretion of bilirubin as a diglucuronide giving the direct van den Bergh reaction. Biochem J (1957) 5.27
Behaviour of 14C- and 131I-labelled plasma proteins in the rat. Int J Appl Radiat Isot (1956) 3.94
Determination of bilirubin glucuronide and assay of glucuronyltransferase with bilirubin as acceptor. Biochem J (1968) 3.91
The preparation of crystalline bilirubin-C14. J Clin Invest (1961) 3.65
Biliary excretion of injected conjugated and unconjugated bilirubin by normal and Gunn rats. Am J Physiol (1961) 3.39
Secretion of organic anions in the formation of urine and bile. Pharmacol Rev (1959) 3.28
Congenital jaundice in rats, due to a defect in glucuronide formation. J Clin Invest (1958) 2.58
Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and gilbert's syndrome. N Engl J Med (1969) 2.21
Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity. Am J Med (1969) 2.09
Factors determining the maximal rate of organic anion secretion by the liver and further evidence on the hepatic site of action of the hormone secretin. J Physiol (1966) 1.91
Hepatic clearance of bilirubin as an index of cellular function in the regenerating rat liver. Br J Exp Pathol (1956) 1.86
Enhancement of glucuronide-conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. N Engl J Med (1966) 1.83
Constitutional nonhemolytic hyperbilirubinemia in the rat: defect of bilirubin conjugation. Proc Soc Exp Biol Med (1957) 1.73
Quantitative separation and determination of bilirubin and conjugated bilirubin in human serum. Clin Chim Acta (1962) 1.64
METABOLISM AND DISPOSITION OF C14-BILIRUBIN IN CONGENITAL NONHEMOLYTIC JAUNDICE. J Clin Invest (1963) 1.63
INHIBITORY ASPECTS OF BILE SECRETION. Nature (1963) 1.52
THE ESTIMATION OF BILIRUBIN IN LIVER. Clin Chim Acta (1965) 1.47
Effect of sodium phenobarbital on bilirubin metabolism in an infant with congenital, nonhemolytic, unconjugated hyperbilirubinemia, and kernicterus. J Clin Invest (1969) 1.42
The sources of bile pigment in the rat: studies of the "early labeled" fraction. J Clin Invest (1966) 1.42
Vascular-extravascular exchange of II31 plasma proteins in the rat. Am J Physiol (1959) 1.39
Organic anion-binding protein in rat liver: drug induction and its physiologic consequence. Proc Natl Acad Sci U S A (1969) 1.38
Studies on the mechanism of phenobarbital-enhanced sulfobromophthalein disappearance. J Pharmacol Exp Ther (1968) 1.37
Enhanced formation of rapidly labelled bilirubin by phenobarbital: hepatic microsomal cytochromes as a possible source. Biochem Biophys Res Commun (1966) 1.28
Biosynthesis of tritiated bilirubin and studies of its excretion in the rat. J Lab Clin Med (1966) 1.19
Effect of phenobarbital on the excretion of an exogenous bilirubin load. Biochem Pharmacol (1967) 1.14
Maximum biliary excretion of bilirubin and sulfobromophthalein during anesthesia-induced alteration of rectal temperature. Proc Soc Exp Biol Med (1967) 1.07
Studies on the biosynthesis production of bilirubin-C14: an improved method utilizing delta-aminolevulinic acid-4-C14 in dogs. J Lab Clin Med (1966) 1.03
The significance of the direct-reacting fraction of serum bilirubin in hemolytic jaundice. Am J Med (1959) 1.03
Barbiturate enhancement of bilirubin conjugation and excretion in young and adult animals. Pediatr Res (1968) 1.02
Re-evaluation of the influence of sex, age pregnancy, and phenobarbital on the activity of UDP-glucuronyl transferase in rat liver. J Lab Clin Med (1969) 1.00
The effect of phenobarbital on hyperbilirubinemia in glucuronyl transferase deficient rats. J Lab Clin Med (1967) 1.00
A defect in microsomal function in nonhemolytic acholuric jaundice. J Histochem Cytochem (1959) 1.00
JAUNDICE WITH CONJUGATED BILIRUBIN IN HYPERHAEMOLYSIS. Acta Med Scand (1964) 0.95
Increased bilirubin conjugation in heterozygous Gunn rats treated with phenobarbital. Nature (1969) 0.92
Metabolism of bilirubin by a clonal strain of rat hepatoma cells. J Cell Biol (1970) 0.91
DIALYZABILITY, PROTEIN BINDING, AND RENAL EXCRETION OF PLASMA CONJUGATED BILIRUBIN. J Clin Invest (1965) 0.88
Production and excretion of bilirubin in Gunn rats treated with phenobarbital. Proc Soc Exp Biol Med (1971) 0.84
Depression of biliary excretion of infused bilirubin in rats and guinea pigs by bile. Am J Physiol (1971) 0.77
Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b'). Immunochemistry (1978) 2.43
Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b. Proc Natl Acad Sci U S A (1977) 2.27
Laparoscopic observations of congenital anomalies of the liver. Gastrointest Endosc (1998) 2.10
Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator. J Immunol (1980) 1.94
Does the mean corpuscular volume help physicians evaluate hospitalized patients with anemia? J Gen Intern Med (1990) 1.89
A novel device of bacterial signal transducers. EMBO J (1994) 1.81
Relation of pancreatic duct hyperplasia to carcinoma. Cancer (1979) 1.78
A novel protein that participates in nonself discrimination of malignant cells by homologous complement. Nat Med (1997) 1.61
Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J Biol Chem (1995) 1.59
Stiffness and elastic behavior of human intracranial and extracranial arteries. J Biomech (1980) 1.56
Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver. J Hepatol (1997) 1.54
Partial purification of bovine plasma kallikreinogen, its activation by the Hageman factor. Biochem Biophys Res Commun (1968) 1.48
The sources of bile pigment in the rat: studies of the "early labeled" fraction. J Clin Invest (1966) 1.42
Exercise and mechanical loading increase periosteal bone formation and whole bone strength in C57BL/6J mice but not in C3H/Hej mice. Calcif Tissue Int (2000) 1.36
Identification of alpha 2-macroglobulin as a carrier protein for IL-6. J Immunol (1989) 1.36
Studies on alpha 2-macroglobulin in bovine plasma. II. Interaction of alpha2-macroglobulin and trypsin. J Biochem (1970) 1.30
Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis. J Immunol (1993) 1.25
The NH-2-terminal sequences of a subunit of the first component of human complement, C1s, and its activated form, C1s. FEBS Lett (1975) 1.25
Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells. FEBS Lett (1996) 1.22
The origins of bilirubin. N Engl J Med (1968) 1.12
Limited chymotryptic cleavage of human C4-binding protein: isolation of a carbohydrate-containing core domain and an active fragment. J Biochem (1982) 1.07
Purification and characterization of a macromolecular weight cofactor for C3b-inactivator, C4bC3bINA-cofactor, of human plasma. Mol Immunol (1980) 1.06
Limited proteolysis of complement protein C3b by regulatory enzyme C3b inactivator: isolation and characterization of a biologically active fragment, C3d,g. J Biochem (1985) 1.04
Bilirubin formation in the liver from nonhemoglobin sources. Experiments with isolated, perfused rat liver. Blood (1965) 1.04
Early-labeled peak of bile pigment in man. Studies with glycine-14C and delta-aminolevulinic acid-3H. N Engl J Med (1967) 1.03
cDNA and deduced amino acid sequence of human PK-120, a plasma kallikrein-sensitive glycoprotein. FEBS Lett (1995) 1.02
Human cell receptor CD46 is down regulated through recognition of a membrane-proximal region of the cytoplasmic domain in persistent measles virus infection. J Virol (1996) 1.01
A gross structure of an activated form of a subunit of the first component of human complement. Clr. FEBS Lett (1975) 1.00
Tanycytic ependymoma in association with neurofibromatosis type 2. Clin Neuropathol (2001) 0.99
Transferrin receptors in developing murine erythroid cells. Br J Haematol (1977) 0.99
Effectiveness of preoperative chemotherapy using carboplatin (CBDCA) and surgery against an esophageal small cell carcinoma. Dis Esophagus (2002) 0.98
Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis. Nephron (1989) 0.98
Generation of C3d,g and C3d by urokinase-treated plasma in association with fibrinolysis. Complement (1985) 0.98
Different sensitivities of the responses of human neutrophils stimulated with immune complex and C5a anaphylatoxin to pertussis toxin. FEBS Lett (1988) 0.96
Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46). Biochem J (1994) 0.96
Surface remodeling vs. whole-cell hemolysis of reticulocytes produced with erythroid stimulation or iron deficiency anemia. Blood (1974) 0.96
A fluorometric method for determination of C3b inactivator. Clin Chim Acta (1982) 0.95
Asymptomatic familial cerebral aneurysms. Neurosurgery (1998) 0.95
Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein. J Biochem (1981) 0.94
Activation of the alternative pathway of complement by apoptotic Jurkat cells. FEBS Lett (1994) 0.93
Increased bilirubin conjugation in heterozygous Gunn rats treated with phenobarbital. Nature (1969) 0.92
Studies on prekallikrein of bovine plasma. I. Purification and properties. J Biochem (1972) 0.91
Metabolism of bilirubin by a clonal strain of rat hepatoma cells. J Cell Biol (1970) 0.91
Mechanical properties of human cerebral arteries. Biorheology (1980) 0.91
Effect of high-impact and low-repetition training on bones in ovariectomized rats. J Bone Miner Res (2001) 0.91
Isolation and cloning of rat poly(ADP-ribose) glycohydrolase: presence of a potential nuclear export signal conserved in mammalian orthologs. J Biochem (1999) 0.91
Efficacy of platelet transfusions in immune thrombocytopenia. Am J Med (1986) 0.91
Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells. J Biochem (1994) 0.90
Structural and functional properties of complement-activating protein M161Ag, a Mycoplasma fermentans gene product that induces cytokine production by human monocytes. J Biol Chem (1998) 0.90
Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46). Immunology (1995) 0.89
Production of erythrogenin by organ cultures of rat kidney. Blood (1972) 0.89
Analysis of commitment of human leukemia HL-60 cells to terminal granulocytic maturation. Cancer Res (1985) 0.89
Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement. Biochem J (1992) 0.89
Differentiation of leukemic cell lines: a review focusing on murine erythroleukemia and human HL-60 cells. Int J Cell Cloning (1985) 0.89
Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen. J Biochem (1979) 0.88
Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis. Am J Pathol (1993) 0.88
Wide-spread distribution of sentinel lymph nodes in esophageal cancer. J Nippon Med Sch (2001) 0.88
Partial purification and some properties of high molecular weight kininogen, bovine kininogen-I. J Biochem (1971) 0.88
Isolation of a complex of the subcomponents of the activated first component of complement, Clr--Cls, from ACD-human plasma. FEBS Lett (1974) 0.88
Limited proteolysis of the third component of human complement, C3, by heat treatment. J Biochem (1981) 0.88
Cytotoxic reduction and regeneration of murine marrow stem cells. Exp Hematol (1983) 0.88
Lipopolysaccharide stimulates HepG2 human hepatoma cells in the presence of lipopolysaccharide-binding protein via CD14. Eur J Biochem (1999) 0.88
Transfer of bilirubin uridine diphosphate-glucuronyltransferase to enzyme-deficient rats. Science (1970) 0.88
The sulphated carbohydrate-protein linkage region isolated from chondroitin 4-sulphate chains of inter-alpha-trypsin inhibitor in human plasma. Glycobiology (1995) 0.88
Rapid spontaneous resolution of acute extradural and subdural hematomas. Case report. J Neurosurg (1993) 0.87
Human plasma prekallikrein as a protein complex. J Biochem (1973) 0.87
Detergent-resistant membrane domains are required for mast cell activation but dispensable for tyrosine phosphorylation upon aggregation of the high affinity receptor for IgE. J Biochem (2001) 0.87
HMW and LMW kininogens. Methods Enzymol (1981) 0.86
Purification and characterization of a novel substrate for plasma kallikrein (PK-120) in human plasma. Biochim Biophys Acta (1994) 0.86
Surface remodelling of reticulocytes produced in response to erythroid stress. Nat New Biol (1972) 0.86
Studies on alpha 2-macroglobulin in bovine plasma. I. Purification, physical properties, and chemical compositions. J Biochem (1970) 0.86
Selective reticulocyte destruction in erythrocyte pyruvate kinase deficiency. J Clin Invest (1971) 0.85
Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAE hybrid, on complement-mediated swine endothelial cell lysis. Transplantation (1994) 0.85
Mobilization of iron from the plasma membrane of the murine reticulocyte. The role of ferritin. Biochim Biophys Acta (1978) 0.85
Computed tomography in intra- and suprasellar epithelial cysts (symptomatic Rathke cleft cysts). AJNR Am J Neuroradiol (1985) 0.85
Labeled bilirubin production by a clonal strain of rat hepatoma cells. Proc Soc Exp Biol Med (1971) 0.85
Cystic lymphangioma of the mediastinum. Am Heart J (1995) 0.85
Separation of a new substrate, kininogen-I, for plasma kallikrein in bovine plasma. J Biochem (1967) 0.85
The CD46 transmembrane domain is required for efficient formation of measles-virus-mediated syncytium. Biochem J (1997) 0.85
Transferrin receptors, iron transport and ferritin metabolism in Friend erythroleukemia cells. Biochim Biophys Acta (1978) 0.85
Studies of 2 -macroglobulin in bovine plasma. 3. Its actions on bovine plasma kallikrein, plasmin and thrombin. J Biochem (1971) 0.84
Decay-accelerating factor on human umbilical vein endothelial cells. Its histamine-induced expression and spontaneous rapid shedding from the cell surface. J Immunol (1994) 0.84
Correlation of serum concentration of alpha 1-acid glycoprotein with lymphocyte blastogenesis and development of experimentally induced or naturally acquired hepatic abscesses in cattle. Am J Vet Res (1992) 0.84
Production and excretion of bilirubin in Gunn rats treated with phenobarbital. Proc Soc Exp Biol Med (1971) 0.84
Iron transport from Sepharose-bound transferrin. Biochem Biophys Res Commun (1977) 0.84
Use of cell separation and short-term culture techniques to study erythroid cell development. Blood (1975) 0.84
Regulation of pancreastatin release from a human pancreatic carcinoid cell line in vitro. Endocrinology (1991) 0.84
[A case of spinal glioblastoma with intracranial dissemination]. No Shinkei Geka (1993) 0.83
Location of the inter-chain disulfide bonds of the third component of human complement. Biochem Biophys Res Commun (1985) 0.83
Complement activation by diesel exhaust particles (DEP). Biol Pharm Bull (1998) 0.83
Molecular cloning of a complementary DNA for a membrane cofactor protein (MCP, CD46)/measles virus receptor on Vero cells and its functional characterization. Biol Pharm Bull (1996) 0.83
CD46 (membrane cofactor protein of complement, measles virus receptor): structural and functional divergence among species (review). Int J Mol Med (1998) 0.83
Unregulated growth of murine leukemic cells and suppression of normal granulocyte growth in diffusion chamber cultures. Blood (1976) 0.83
Evidence that C4b-binding protein is an acute phase protein. Biochem Biophys Res Commun (1989) 0.83
Purification and characterization of the C3 convertase of the classical pathway of human complement system by size exclusion high-performance liquid chromatography. J Biochem (1985) 0.82